Physician

Krystal J Massey, M.D.

According to 2025 Medicare claims, Krystal Massey, M.D. (NPI: 1043630619) practices dermatology in the Cheyenne, WY market, with the plurality of this provider's patient population coming from Laramie, WY. This provider's primary affiliated billing organization is CHEYENNE SKIN CLINIC LLP (NPI: 1740427509; TIN: 263996650) and primary practice location at 82009-3446. Massey is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Massey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,302 traditional Medicare patients, billed 6,461 HCPCS/CPT codes, and received $357,789 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 568 prescription claims across 268 beneficiaries totaling $167,830 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 42 records totaling $37,136. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $51,753 to $357,789. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,391 to $167,830. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$179K$358K2020 Medicare payment: $51,753 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $106,733 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $169,017 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $258,647 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $357,789 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20203431,090$51,753
20215401,701$106,733
20227082,809$169,017
20231,6944,648$258,647
20242,3026,461$357,789

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$106K$212K2015 Drug cost: $1,391 (USD; Tot_Drug_Cst)2020 Drug cost: $8,728 (USD; Tot_Drug_Cst)2021 Drug cost: $83,441 (USD; Tot_Drug_Cst)2022 Drug cost: $138,677 (USD; Tot_Drug_Cst)2023 Drug cost: $211,919 (USD; Tot_Drug_Cst)2024 Drug cost: $167,830 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R12$1,391
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202074126$8,728
2021125283$83,441
2022164401$138,677
2023163380$211,919
2024268568$167,830

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more381530$84
11102Biopsy of related skin growth, first growth178193$59
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more552667$58
88305Pathology examination of tissue using a microscope, intermediate complexity1,5722,980$50
17000Destruction of precancer skin growth, 1 growth252276$38

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab20672$87,858
AcitretinAcitretin291,364$7,597
Clobetasol PropionateClobetasol Propionate761,973$4,184
FluorouracilFluorouracil621,634$4,001
TacrolimusTacrolimus13361$1,913

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.38$420ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.4$36,715SANOFI US SERVICES INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Krystal J. Massey, M.D.?

Tedicare shows public-source Medicare data for Krystal J. Massey, M.D. (NPI 1043630619), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Krystal J. Massey, M.D. have ACO affiliation data?

Krystal J. Massey, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Krystal J. Massey, M.D.?

Krystal J. Massey, M.D. is linked to CHEYENNE SKIN CLINIC LLP (billing NPI 1740427509) in the available physician profile data.

Does Krystal J. Massey, M.D. have Open Payments data?

Krystal J. Massey, M.D. has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.